IDO2 and breast cancer: Pei et al. demonstrated that SNHG1 suppressed the differentiation of Treg cells by sponging miR-448 to upregulate the expression of indoleamine 2,3-dioxygenase (IDO), enhancing the mediated immune escape of breast cancer cells [78].